Crown Advisors Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,000
| Closed | -$554K | – | 42 |
|
|
2024
Q1 | $554K | Hold |
30,000
| – | – | 0.34% | 43 |
|
|
2023
Q4 | $939K | Hold |
30,000
| – | – | 0.64% | 40 |
|
|
2023
Q3 | $625K | Hold |
30,000
| – | – | 0.44% | 44 |
|
|
2023
Q2 | $718K | Hold |
30,000
| – | – | 0.47% | 49 |
|
|
2023
Q1 | $564K | Buy |
+30,000
| New | +$564K | 0.42% | 45 |
|
|
2022
Q4 | – | Sell |
-30,000
| Closed | -$490K | – | 43 |
|
|
2022
Q3 | $490K | Buy |
+30,000
| New | +$490K | 0.49% | 42 |
|